Pholedrine: A substitute for hydroxyamphetamine as a diagnostic eyedrop test in Horner's syndrome

16Citations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Mydriatic responses to eyedrops containing the indirect acting sympathomimetic amines tyramine, hydroxyamphetamine, and pholedrine have been compared in 10 healthy subjects. Pholedrine, the n-methyl derivative of hydroxyamphetamine, at a concentration of 1% had effects similar to those produced by 0.5% hydroxyamphetamine itself. Pretreatment with topical guanethidine attenuated its responses and in 13 patients with unilateral Horner's syndrome it distinguished clearly those five patients who had preganglionic from the eight with postganglionic lesions. It is concluded that 1% pholedrine may be substituted for 0.5% hydroxyamphetamine, which is no longer available, as a diagnostic agent for use in Horner's syndrome.

Cite

CITATION STYLE

APA

Bates, A. T., Chamberlain, S., Champion, M., Foley, L., Hughes, E., Jani, B., … Smith, S. E. (1995). Pholedrine: A substitute for hydroxyamphetamine as a diagnostic eyedrop test in Horner’s syndrome. Journal of Neurology Neurosurgery and Psychiatry, 58(2), 215–217. https://doi.org/10.1136/jnnp.58.2.215

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free